689 Results

People

  1. Brennan
    Brennan
  2. Jarnagin
    Jarnagin
  3. Fong
    Fong
  4. DeMatteo
    DeMatteo
  5. Gonen
    Gonen
  6. Rusch
    Rusch
  7. Blumgart
    Blumgart
  8. D'Angelica
    D'Angelica
  9. Motzer
    Motzer
  10. Scher
    Scher

Groups

  1. Department of Medicine (299)
  2. Surgery (247)
  3. Solid Tumor Oncology Division (210)
  4. Survivorship Research (117)
  5. Epidemiology and Biostatistics (104)
  6. Biostatistics Service (95)
  7. Center for Pancreatic Cancer Research (89)
  8. Center for Hematologic Malignancies (86)
  9. Hematologic Malignancies, Division of (83)
  10. Sloan Kettering Institute Faculty (72)
  1. "survival time"
Formats
  1. Journal Article (663)
  2. Conference Paper (11)
  3. Editorial (8)
  4. Review (4)
  5. Correspondence (1)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (299)
  2. Surgery (247)
  3. Solid Tumor Oncology Division (210)
  4. Survivorship Research (117)
  5. Epidemiology and Biostatistics (104)
  6. Biostatistics Service (95)

More Groups

People
  1. Murray Brennan (32)
  2. William Jarnagin (26)
  3. Yuman Fong (25)
  4. Ronald DeMatteo (24)
  5. Mithat Gonen (23)
  6. Valerie Rusch (22)

More People

Years
  1. 2025 (7)
  2. 2024 (14)
  3. 2023 (11)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (21)

More Years

Publications
  1. Cancer (38)
  2. Journal of Clinical Oncology (29)
  3. International Journal of Radiation Oncology, Biology, Physics (24)
  4. Gynecologic Oncology (23)
  5. Annals of Surgical Oncology (21)
  6. Annals of Oncology (19)

More Publications

Publishers
  1. Elsevier Inc. (127)
  2. Springer (66)
  3. Elsevier Science, Inc. (53)
  4. Wiley Blackwell (51)
  5. Lippincott Williams & Wilkins (48)
  6. Oxford University Press (38)

More Publishers

Results (689)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A plain language summary of NALIRIFOX compared with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer (NAPOLI 3)
    Editorial

    Wainberg, Z. A.; Melisi, D.; Macarulla, T.; Pazo Cid, R.; Chandana, S. R.; De La Fouchardière, C.; Dean, A.; Kiss, I.; Jin Leei, W.; Goetze, T. O.; more...
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study
    Journal Article

    Bedard, P. L.; Jhaveri, K. L.; Accordino, M. K.; Cervantes, A.; Gambardella, V.; Hamilton, E.; Italiano, A.; Kalinsky, K.; Krop, I. E.; Oliveira, M.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
    Journal Article

    O'Shaughnessy, J.; Tolaney, S. M.; Yardley, D. A.; Hart, L.; Razavi, P.; Fasching, P. A.; Janni, W.; Schwartzberg, L.; Kim, J.; Akdere, M.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Impact of postprogression therapies on overall survival: Recommendations from the 2023 Kidney Cancer Association think tank meeting
    Review

    Berg, S. A.; La Rosa, S.; Zhang, T.; Pierorazio, P. M.; Albiges, L.; Beckermann, K. E.; Campbell, M. T.; Carlo, M. I.; Coleman, K.; George, D. J.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Adding metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic breast cancer (EXTEND): A multicenter, randomized phase 2 trial
    Journal Article

    Reddy, J. P.; Sherry, A. D.; Fellman, B.; Liu, S.; Bathala, T.; Haymaker, C.; Cohen, L.; Smith, B. D.; Ramirez, D.; Shaitelman, S. F.; more...
    International Journal of Radiation Oncology, Biology, Physics (2025)

    Fulltext@MSK | Save
  • The Society of Thoracic Surgeons (STS) clinical practice guideline on surgical management of oligometastatic non-small cell lung cancer
    Guidelines

    Antonoff, M. B.; Mitchell, K. G.; Kim, S. S.; Salfity, H. V.; Kotova, S.; Ripley, R. T.; Neri, A. L.; Sood, P.; Gandhi, S. G.; Elamin, Y. Y.; more...
    Annals of Thoracic Surgery (2025)

    Fulltext@MSK | Save
  • Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma
    Journal Article

    Lenz, J. A.; Peng, B.; Assenmacher, C.; King, A.; Zhang, P. J.; Maki, R. G.; Blanco, M. A.; Radaelli, E.; Atherton, M. J.
    Cancer Immunology, Immunotherapy (2025)

    Fulltext@MSK | Save
  • Long-term outcomes after percutaneous cryoablation of abdominal wall endometriosis
    Journal Article

    Marcelin, C.; Maas, P.; Jambon, E.; Maaloum, R.; Andreo, I. M.; Le Bras, Y.; Roman, H.; Grenier, N.; Brun, J. L.; Cornelis, F. H.
    European Radiology (2024)

    Fulltext@MSK | Save
  • Clinical networking results in continuous improvement of the outcome of patients with acute promyelocytic leukemia
    Journal Article

    Koury, L. C. D. A.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Glória, A. B.; Pagnano, K.; Nunes, E. C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States
    Journal Article

    Tolaney, S. M.; Punie, K.; Carey, L. A.; Kurian, A. W.; Ntalla, I.; Sjekloca, N.; Shah, A.; Rehnquist, M. K.; Stokes, M.; Fraeman, K.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save